Lunate Capital LTD Revolution Medicines, Inc. Transaction History
Lunate Capital LTD
- $171 Billion
- Q1 2025
A detailed history of Lunate Capital LTD transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Lunate Capital LTD holds 2,196,200 shares of RVMD stock, worth $88.7 Million. This represents 45.36% of its overall portfolio holdings.
Number of Shares
2,196,200Holding current value
$88.7 Million% of portfolio
45.36%Shares
1 transactions
Others Institutions Holding RVMD
# of Institutions
298Shares Held
171MCall Options Held
920KPut Options Held
1.06M-
Vanguard Group Inc Valley Forge, PA17.1MShares$690 Million0.01% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$541 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.2MShares$535 Million3.09% of portfolio
-
Janus Henderson Group PLC London, X09.48MShares$383 Million0.22% of portfolio
-
Baker Bros. Advisors LP New York, NY7.94MShares$320 Million3.85% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.54B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...